SCHEMBL1018678

SCHEMBL1018678

O=C(CCl)NCCCC1CCCC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
SIGMAR1 Q99720 2/20 0.52
EPHX1 P07099 2/20 0.43
MEN1 O00255 1/20 0.43
RAB9A P51151 1/20 0.43
KMT2A Q03164 1/20 0.43
KEAP1 Q14145 1/20 0.42
NFE2L2 Q16236 1/20 0.42
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
HDAC9 Q9UKV0 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8395020 0.80 SIGMAR1 (0.48) ALDH1A1SIGMAR1EPHX1MEN1RAB9A
SCHEMBL10632220 0.79 NMT1 (0.49) ALDH1A1SIGMAR1EPHX1MEN1RAB9A
SCHEMBL21882669 0.79 KDM5A (0.50) ALDH1A1SIGMAR1EPHX1MEN1RAB9A
SCHEMBL8395918 0.78 KDM4E (0.52) ALDH1A1SIGMAR1EPHX1MEN1KMT2A
SCHEMBL8394917 0.78 EPHX1 (0.49) ALDH1A1SIGMAR1EPHX1HPGDADAMTS4
SCHEMBL8396348 0.78 EPHX1 (0.49) ALDH1A1SIGMAR1EPHX1HPGDADAMTS4
SCHEMBL11306651 0.78 CYP2D6 (0.50) SIGMAR1EPHX1MEN1RAB9AKMT2A
SCHEMBL24193476 0.78 KEAP1 (0.57) ALDH1A1SIGMAR1EPHX1RAB9AKMT2A
SCHEMBL20016275 0.78 ALDH1A1 (0.58) ALDH1A1SIGMAR1MEN1RAB9AKMT2A
SCHEMBL8078349 0.77 TSHR (0.47) SIGMAR1EPHX1HPGDADAMTS4ADAMTS5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011000945-A9 AMINOALKAMIDES FOR USE IN THE TREATMENT OF INFLAMMATORY, DEGENERATIVE OR DEMYELINATING DISEASES OF THE CNS NENSIUS RESEARCH A/S (DK) 2011-04-07 WO disclosed
WO-2011000945-A2 AMINOALKAMIDES FOR USE IN THE TREATMENT OF INFLAMMATORY, DEGENERATIVE OR DEMYELINATING DISEASES OF THE CNS NENSIUS RESEARCH A/S (DK) 2011-01-06 WO disclosed